Commercial strategies are often developed months before execution, but today's life sciences environment rarely stands still. Regulatory uncertainty, competitive activity, new data and shifting customer expectations can quickly challenge even the most carefully constructed plans. According to Swathi Rangan, partner and commercial strategy lead at Acumetis, organizations should treat brand plans as living frameworks designed to evolve as new information emerges.
In this video interview, Rangan discusses how companies can distinguish meaningful market signals from noise, build decision triggers into commercial planning and prepare for multiple future scenarios. She also examines the growing importance of cross-functional collaboration, arguing that commercial teams should be involved much earlier in development to help shape decisions that influence launch readiness and long-term success.
The conversation also explores market development strategies for both emerging and established therapy categories, along with approaches to lifecycle planning that extend beyond launch. Throughout the discussion, Rangan emphasizes adaptability, organizational alignment and continuous learning as critical capabilities for companies navigating an increasingly dynamic market environment.
The editorial staff had no role in this post's creation.